Main Stage Headliners
Speakers on the ATA2023 Main Stage
Meet the industry titans and on-the-ground changemakers who will be on the ATA2023 main stage, who are redefining how we deliver care. This is the platform where thought leaders share their insights and challenge the status quo, to stimulate important discussion and ongoing learning and the exchange of ideas throughout the conference.
Joe Coughlin, PhD
Founder & Director, MIT AgeLab
Kristi Henderson, DNP, NP-C, FAAN, FAEN
Chair, ATA; CEO, MedExpress; Senior VP, Center for Digital Health & Innovation, Optum Health
Joseph Kvedar, MD
Immediate Past Chair, ATA; Professor, Harvard Medical School; Editor-in-Chief, npj Digital Medicine; Senior Advisor, MGH Center For Innovation in Digital HealthCare
Thomas A. Mason, MD
Chief Medical Officer, Office of the National Coordinator for Health Information Technology, HHS
Senior Director, Global Digital Health Strategy & Regulatory, Google
British A. Robinson
President & CEO, Barbara Bush Foundation
John J. Whyte, MD, MPH
Chief Medical Officer, WebMD
Sree Chaguturu, MD
Executive Vice President and Chief Medical Officer, CVS Health
Partner, Morgan Health
Best-selling author of Hacking Healthcare
Chief Executive Officer, Transcarent
Executive Chairman, Caption Health and Treasurer, the ATA
Senior Advisor, Centers for Medicare & Medicaid Services
Melynda Barnes, MD
Patrick Carroll, MD
Executive Producer & Host, WTF Health
CEO & Co-Founder, Seqster
Chairman and Founding Board Member, YourCoach Health
Health Industry Executive, Microsoft
Chair Global Health and Purpose, FINN Partners
U. Michael Currie
Senior Vice President and Chief Health Equity Officer, United Health Group
Felix Manuel Chinea
Senior Manager, Health Equity & Inclusion Strategy, Doximity
Joe Coughlin, PhD
Dr. Joe Coughlin leads the Massachusetts Institute of Technology AgeLab. Researcher, teacher & advisor – his work explores how global demographics, technology and changing behaviors are transforming business & society. He teaches in MIT’s Department of Urban Studies & Planning. Coughlin advises major companies worldwide and has served on advisory committees for the White House, the Organization for Economic Cooperation & Development and economic development authorities worldwide. He was recognized by the Wall Street Journal as inventing the future of retirement, named as one of “100 Most Creative in Business” by Fast Company Magazine, and one of Investment News 2019 “Icons & Innovators.” Coughlin is a Senior Contributor to Forbes and writes for the Wall Street Journal as well as other leading business outlets. Author of over 100 academic publications, his recent book is The Longevity Economy: Unlocking the World’s Fastest Growing, Most Misunderstood Market – was named a CEO READS Best Seller. Follow him on Twitter @josephcoughlin.
Kristi Henderson, DNP, NP-C, FAAN, FAEN
A digital health leader and clinician with over 25 years of experience designing, implementing and optimizing the health care delivery system using digital health tools and technology.
Kristi Henderson is the CEO for MedExpress and SVP of The Center for Digital Health & Innovation for Optum Health, where she is creating a first-of-its-kind connected health ecosystem using industry-leading digital health tools and telehealth.
She most recently led clinical operations for Amazon Care, a healthcare initiative for Amazon employees and their families.
Before joining Amazon, she designed and launched a national solutions center for patient access, virtual care, and care coordination for Ascension Health.
She has a proven track record of delivering successful programs at scale that improve health and save money.
She is an adjunct faculty member in Population Health at the Dell Medical School at the University of Texas-Austin and at the University of Washington School of Nursing.
Henderson thrives with complex challenges and consistently delivers results that exceed expectations.
She is known for her ability to execute and sustain these models in advance of them becoming an industry standard as evidenced by her first launch of a telehealth program in 2003 which is recognized as one of only two of HRSA’s Centers of Excellence.
She is resourceful, collaborative and known for her creative solutions that engage patients and empower clinicians.
She has testified before multiple U.S. Senate committees and given numerous presentations across the country, including a TEDx, to advance telehealth policy and share innovative new models of care.
A few of her other leadership roles include service as an executive board member for the American Telemedicine Association; Association of American Medical Colleges Telehealth Committee member, American Nurses Association co-chair for Committee on Connected Health and National Quality Forum Telehealth Committee.
She is a Fellow in the American Academy of Nursing and the Emergency Nurses Association and an honorary Dean at the University of Washington School of Nursing.
Henderson received her Doctor of Nursing Practice degree from the University of Alabama at Birmingham where she was recognized as the 2019 Distinguished Alumna from the School of Nursing. She maintains national certification as a family and acute care nurse practitioner.
Joseph Kvedar, MD
At Partners HealthCare, Dr. Joe Kvedar has focused on driving innovation, creating the market, and gaining acceptance for connected health for nearly three decades. He is now applying his expertise, insights, and influence to advancing adoption of telehealth and virtual care technologies at the national level. He is Professor of Dermatology at Harvard Medical School, Immediate Past Chair of ATA (The American Telemedicine Association), Co-Chair of the AMA’s Digital Medicine Payment Advisory Group, and Editorin-Chief of npj Digital Medicine, a Nature Research journal. He is the author of two books on digital health: The Internet of Healthy Things (2015) and The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan (2017). The cHealth Blog provides his insights and vision for digital health. Dr. Kvedar is an advisor to and serves on the board of several Venture Capital Firms and digital health companies.
Thomas A. Mason, MD
Dr. Thomas Mason is Chief Medical Officer (CMO) of the Office of the National Coordinator for Health Information Technology (ONC) at the U.S. Department of Health and Human Services (HHS). As CMO he is a health IT and stakeholder ambassador for ONC, routinely meeting with clinicians in the field and advocates across the healthcare industry, focusing on improving health IT usability, reducing clinician burden, and advancing ONC’s mission to improve data use and its availability across the health care spectrum. Working closely with staff at the Centers for Medicare & Medicaid (CMS) and other agencies within HHS, Dr. Mason leads efforts to better understand and address clinical documentation burdens and other administrative burdens relating to the use of electronic health records. Dr. Mason led the development of ONC’s Health IT Playbook, which offers tools, resources, and best practices to help address the challenges of implementing, adopting and optimizing health IT.
Prior to joining ONC, Dr. Mason worked at the Cook County Health and Hospitals System (CCHHS), the third largest public hospital system in the country. He spent 14 years as a board-certified internist with an emphasis on primary care and preventative medicine and led the charge to implement EHRs across the system. His work at CCHHS allowed specialists and primary care providers to streamline and optimize EHR use, improving clinical workflow and system efficiency. Dr. Mason has brought his experience implementing multiple EHRs to ONC to help the agency better understand the difficulties clinicians experience with health IT and to help facilitate collaboration between the government and the healthcare industry to improve clinicians’ and patients’ engagement with innovative health technologies.
Dr. Mason earned his M.D. from the University of Illinois College of Medicine and completed his residency in Internal Medicine at Rush University Medical Center and Cook County Hospital.
Bakul Patel is the Senior Director, Global Digital Health Strategy & Regulatory focused on helping build a unified digital health strategy for Health@Google that is aligned with the global regulatory needs. Mr. Patel’s vision for his role at Google is to help realize the potential of digital health that is poised to be a gamechanger in heralding a new era for healthcare generally.
Prior to joining Google, Mr Patel held the position of the Chief Digital Health Officer of Global Strategy and innovation and Director for Digital Health Center of Excellence, at the US Food and Drug Administration (FDA) providing thought leadership and shaping responsible regulation for this emerging field of Digital Health.
He is most known for coining the term “Software as a Medical device” (SaMD) and building a risk framework for medical device regulators globally. He was also the architect of the software precertification pilot program and the framework for Artificial Intelligence/Machine Learning (AI/ML)-Based Software.
British A. Robinson
British A. Robinson is a visionary leader with more than 20 years of experience leading initiatives in international and domestic health, corporate social responsibility, public-private partnerships, government relations, and advocacy and policy development.
As the President and Chief Executive Officer of the Barbara Bush Foundation for Family Literacy, British oversees the strategic direction and all operations of the public charity, which was established by former First Lady Barbara Bush in 1989.
Prior to joining the Barbara Bush Foundation, British was founding CEO of the Women’s Heart Alliance, where she oversaw all aspects of the initiative, including its education/awareness campaign, advocacy and fundraising efforts, operations, program implementation, and strategic alliances. Her extensive nonprofit leadership experience also includes service as Senior Vice President of Innovation and Strategic Initiatives at Women for Women International and as Vice President of Global Strategy and Programs at Susan G. Komen. British also served at the U.S. Department of State as the Deputy Coordinator/Director of Private Sector Engagement for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), where she was responsible for the U.S. Government’s successful establishment of public-private partnerships at the international, national, and enterprise levels to strengthen HIV/AIDS initiatives.
Additionally, during her tenure at the State Department, she held a special assignment as Director and Special Advisor to the Secretary’s Office of Global Women’s Issues, where she established and managed alliances and partnerships committed to advancing the rights of women and girls around the world.
Earlier in her career, British worked for the Jesuit Conference/Jesuit Refugee Services USA as the Director of Social and International Ministries, Citigroup/Citibank in retail banking, and served in the Jesuit Volunteer Corps (JVC).
John J. Whyte, MD, MPH
Dr. John Whyte is a physician and author with a unique combination of government and private sector work that provides him with an exceptional perspective on wellness, clinical trials, information technology, innovation, and health care services.
He is currently the Chief Medical Officer, WebMD. In this role, Dr. Whyte leads efforts to develop and expand strategic partnerships that create meaningful change around important and timely public health issues. He has been a leading voice in addressing the COVID pandemic, being named as one of the top 20 health influencers. Dr. Whyte is also a major contributor to iterating digital platforms from simply providing content, to instead playing a pivotal role in connecting to care.
Prior to WebMD, Dr. Whyte served as the Director of Professional Affairs and Stakeholder Engagement at the Center for Drugs Evaluation and Research at the U.S. Food and Drug Administration. In this role, Dr. Whyte spearheaded numerous efforts to address diversity in drug development programs especially as it relates to necessary changes in clinical trial design. This includes strategies around patient recruitment and acquisition, as well as the use of adaptive clinical trial design and master protocols. Dr. Whyte also helped provide regulatory insight into the potential uses of real-world evidence in regulatory decisions, especially around patient-focused drug development. Dr. Whyte led a research agenda around drug safety issues, including prescription and over-the-counter products.
Prior to this, Dr. Whyte worked for nearly a decade as the Chief Medical Expert and Vice President, Health and Medical Education at Discovery Channel. Dr. Whyte developed, designed and delivered educational programming that appealed to both a medical and lay audience. He provided strategic direction, aligning medical and public health interests, viewer demands and corporate funding opportunities. His shows run numerous awards, including Tellys and CINE Golden Eagle.
Dr. Whyte also served in numerous leadership roles at the Centers for Medicare & Medicaid Services. While there, he formalized the process by which the Medicare program determines coverage decisions, including the criteria meant by “medically necessary and reasonable.” He helped determine, evaluate and implement the national Medicare coverage policies on multiple products and services. He also oversaw an ongoing analysis of innovative treatment patterns and activities that improve health care outcomes. He is a recognized expert on various payment policies and models.
Dr. Whyte is a board-certified internist and continues to see patients. He completed an internal medicine residency at Duke University Medical Center as well as earned a Master of Public Health (MPH) in Health Policy and Management at Harvard University School of Public Health. Prior to arriving in Washington, Dr. Whyte was a health services research fellow at Stanford and attending physician in the Department of Medicine. He has written extensively in the medical and lay press, including numerous best-selling books.
Sree Chaguturu, MD
Sree Chaguturu, MD is executive vice president and chief medical officer of CVS Health®. He leads the CVS Health medical affairs organization spanning Aetna®, CVS Caremark®, CVS Pharmacy®, MinuteClinic®, women’s health and genomics, data and analytics, patient safety and health equity.
Sree is focused on advancing the highest possible clinical quality standards, increasing access to care, improving patient outcomes and reducing overall health care costs across the CVS Health enterprise.
Sree previously served as chief medical officer of CVS Caremark, the company pharmacy benefits management (PBM) business, where he provided clinical oversight for the pharmacy benefits design strategy. Additionally, he has served as a trusted advisor to employer and health plan clients, their members and CVS Health colleagues throughout the COVID-19 pandemic.
Before joining CVS Health, Sree was chief population health officer of Mass General Brigham, the largest health care system in Massachusetts. He led the system’s accountable care organization and numerous clinical care delivery and innovation programs. He is also a practicing internal medicine physician at Massachusetts General Hospital.
Sree earned his bachelor’s degree in biology from Brown University and his doctorate of medicine from Brown University Medical School. He completed his internal medicine and primary care training at Massachusetts General Hospital.
Follow Sree on LinkedIn and Twitter to learn more about him.
Dr. Cheryl Pegus is a Partner at Morgan Health supporting the Morgan Health Ventures team.
Dr. Pegus joins Morgan Health from Walmart, where she served as Executive Vice President of Health & Wellness, leading the company’s bold health care vision and consumer-facing programs designed to raise the standard of care for millions of Americans. She has been consistently recognized as one of the most influential clinical executives in the country.
Dr. Pegus brings more than 20 years of experience across the health sector to support Morgan Health’s vision and mission. Prior to joining Walmart, Dr. Pegus served as President of Consumer Solutions and Chief Medical Officer for Cambia Health Solutions. She also served as the first chief medical officer at Walgreens and as General Manager and Chief Medical Officer for SymCare Personalized Health Solutions, a diabetes-focused division of Johnson & Johnson. Dr. Pegus also had roles at Pfizer, where she focused on the development of clinical protocols and early disease management programs, and Aetna, where her work supported a focus on wellness, women’s health, health equity initiatives and predictive analytics. She began her career in private practice as a cardiologist and previously served as board chair for the Association of Black Cardiologists. Dr. Pegus is co-founder of A New Beat and has served on the board of the American Heart Association as well as public and private companies.
In addition to her role at Morgan Health, Dr. Pegus will continue to serve as a senior advisor to Walmart and will be joining Atria.
Dr. Pegus received her bachelor’s degree from Brandeis University and her medical doctorate from Weill Cornell Medical College. She received her master’s degree in Public Health from Columbia University Mailman School of Public Health.
Strategic advisor to provider, payer and life science organizations in the Americas. Create enterprise-wide AI initiatives designed to transform healthcare at scale. Focus on technological, process and cultural redesign leading to the creation of Intelligent Health Systems that empower patients, consumers and clinicians to be their best.
As CEO of Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers and their families, Glen helps change the consumer healthcare experience. Born in Silicon Valley, Transcarent’s platform empowers consumers with the kind of information, guidance and access that leads to better care, better outcomes, and more cost-effective decisions for everyone.
Joseph DeVivo leads the hospital and health system business unit for Teladoc Health. Under his direction, the integrated platform and hardware business addresses the comprehensive needs of hospitals, health systems, retail clinics, and physician groups, globally.
Having spent her entire career in healthcare, Robin Glasco brings an acute understanding and unique perspective of the industry. A Washington, D.C.-based member of Spencer Stuart’s Healthcare and Insurance practices, Robin is a strategist and innovator, helping healthcare leaders reimagine and transform their organizations.
The CMS Innovation Center has a growing portfolio testing various payment and service delivery models that aim to achieve better care for patients, better health for our communities, and lower costs through improvement for our health care system.
On ‘WTF Health – What’s the Future, Health?’ I talk to health tech insiders about the innovations and new business models that are transforming health and the healthcare industry. From virtual care to data analytics, personalized medicine to digital health, I’m talking with the startups, investors, and incumbents working to change the future of health worldwide.
Ardy Arianpour is CEO & Co-Founder of SEQSTER the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in biotech, life sciences and digital health. Prior to starting SEQSTER, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.
As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country.
Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was a Medical, Marketing, and Media’s (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40. Ardy is on the Digital Health Advisory Board of UCSD and Faculty for NextMed.Health. He is known for coining the term “Health Data is Medicine™”.
Eugene is a serial intra and entrepreneur, executive, venture builder, speaker & board advisor focusing on digital health. Eugene is a Chairman and Founding Board Member at YourCoach Health and founder of Initium Impact Ventures. Before YourCoach, Eugene served as a Global Head of Digital Health at Bayer. He has also co-founded and sold a doctor rating startup and a consulting company. Eugene enjoys running, writing, traveling, and spending time with his family.
Kim is a Healthcare Industry Leader on the World Wide Commercial Team at Microsoft. In this role she works closely with health systems and payors on driving digital transformation. Prior to working at Microsoft Kim was the Group Vice President of Telehealth and Health Tech Strategy at Providence St.
FINN Partners is one of the fastest-growing global, independent agencies with a heart and a conscience. We serve clients through a powerful combination of hands-on partnership, highly specialized expertise, and a values-driven culture that champions integrity, collaboration, and innovation. More than an agency, we are a bold collective of communications advocates, stewarding brands, protecting reputations, influencing public policy, and leveraging data and analytics to shape the most important conversations of our day. Honored to be among the founding members of its award-winning FINN Global Health Practice and to champion health throughout the agency.
U. Michael Currie
Michael is the Senior Vice President and Chief Health Equity Officer at UnitedHealth Group. He has led the coordination of health equity efforts across UnitedHealth Group since June of 2010. Michael is responsible for the development and execution of enterprise efforts, initiatives, and interventions to identify health disparities, as well as the enhancement or implementation of programs, services and strategies to address identified health disparities.
Felix Manuel Chinea
Dr. Félix Manuel Chinea is a Puerto Rican military brat raised in the South and currently growing roots in Durham, North Carolina with his amazing wife, Raha, and lovable dog, Âbi (aw-bee), which means blue in Farsi.
He is a graduate of Duke University School of Medicine with experience in health disparities and health equity research. Through this work, he highlighted the need for disaggregated data within the Latine community to address disparities in prostate cancer outcomes. Similar to many BIPOC physicians, he felt that academic medicine was not aligned with him thriving and impacting healthcare in the way he wanted.”